MBBP client IntegraGen, Inc., a French biotech company, announced it will be opening a U.S. subsidiary in Cambridge, Massachusetts which will help to conduct its clinical research initiatives on early identification of children at risk of autism. IntegraGen’s corporate headquarters is located in Evry, France where it focuses on gene discovery and providing state of the art genotyping services to the research community through the Company’s Genetic Services Business. IntegraGen CEO, Dr. Bernard Courtieu, discusses the benefits of the expansion:
We have decided to locate IntegraGen’s U.S. subsidiary in Cambridge as a result of Massachusetts’ commitment to attracting and supporting the life sciences, the proximity to world-renowned academic institutions, and the highly qualified talent pool in the area. We believe this will be an ideal location to support our strategic business efforts in the United States and further strengthen the strong ties between biotechnology companies based in France and the Commonwealth of Massachusetts.
Click here to see the full press release.